Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model

Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

Vered Stearns · JNCI Journal of the National Cancer Institute · 2003 · 849 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The Human Estrogen Receptor-α Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators

Ashini L. Wijayaratne, Donald P. McDonnell · Journal of Biological Chemistry · 2001 · 422 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Comparison of Endometrial Changes among Symptomatic Tamoxifen-Treated and Nontreated Premenopausal and Postmenopausal Breast Cancer Patients

Wen‐Fang Cheng, Ho‐Hsiung Lin, Pao‐Ling Torng et al. · Gynecologic Oncology · 1997 · 137 citations

Medicine, Gynecology, Oncology +14

Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60

Fredric J. Cohen · Obstetrics and Gynecology · 2000 · 110 citations

Medicine, Gynecology, Pharmacotherapy +12

Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles1

Valerie L. Baker, Michael Draper, Sofia Paul et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 95 citations · Full text

Medicine, Endocrinology, Pharmacology +12